Physician profile
Marbie N Becton
NPI 1750943726
$725.39
in general payments reported to CMS, 2019-2025
16 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $127 · 2022: $161 · 2023: $57.45 · 2024: $267 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $437.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $127.38 | 2021 | |
| Abbvie INC. | $125.00 | 2022 | |
| Smith+Nephew, INC. | $119.61 | 2024-2025 | Collagenase Santyl, Regranex |
| Itamar Medical INC | $57.45 | 2023 | Watchpatone |
| Merck Sharp & Dohme LLC | $53.49 | 2024 | Gardasil, Capvaxive, Gardasil 9 |
| Takeda Pharmaceuticals U.S.A., INC. | $51.78 | 2024-2025 | Trintellix |
| Lilly USA, LLC | $37.00 | 2024 | Mounjaro |
| Axsome Therapeutics, INC. | $20.56 | 2024 | Auvelity |
| Cequr Corporation | $20.50 | 2025 | Cequr Simplicity |
| Kowa Pharmaceuticals America, INC. | $19.71 | 2022 | |
| Pfizer INC. | $18.20 | 2024 | |
| Evoke Pharma, INC. | $16.35 | 2024 | |
| Esperion Therapeutics, INC. | $16.20 | 2022 | |
| Paratek Pharmaceuticals, INC. | $15.54 | 2025 | Nuzyra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.36 | 2024 | Xifaxan |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.26 | 2024 | Synjardy, Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marbie Becton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.